On November 10, 2022, Living Cell Technologies Ltd announced the results in General Meeting of shareholders that Robert Moyse Willcocks, Andrew Kelly and Bernard Touch resolution have been withdrawn as directors and David Richard Hainsworth and Bradley John has been appointed as a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 AUD | 0.00% | 0.00% | +10.00% |
08/03 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
28/02 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+10.00% | 12.41M | |
+9.30% | 115B | |
+11.75% | 106B | |
-2.13% | 21.96B | |
-14.39% | 21.87B | |
-5.29% | 19.21B | |
-4.17% | 18.08B | |
-38.29% | 17.71B | |
+8.22% | 14.32B | |
+36.95% | 12.42B |
- Stock Market
- Equities
- 1AI Stock
- News Algorae Pharmaceuticals Limited
- Declaration of Voting Results by Living Cell Technologies Ltd